Overview

Effect of Tolvaptan on Cognitive Function in Cirrhosis

Status:
Completed
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
Hypothesis: Tolvaptan will improve cognitive function, brain edema and health-related quality of life in cirrhotic patients with hyponatremia
Phase:
Phase 3
Details
Lead Sponsor:
Hunter Holmes Mcguire Veteran Affairs Medical Center
Collaborator:
Otsuka America Pharmaceutical
Treatments:
Tolvaptan